SPONSOR
University Hospital, Akershus
Total Trials
3
Recruiting
3
Phases
Phase 2
Conditions studied: Breast CancerMetastatic Breast CancerCancer Therapy-Related Cardiac DysfunctionCardiotoxicityHeart FailureDiabetic Foot UlcerPediatric Respiratory DiseasesCOVIDFatigue Post Viral
University Hospital, Akershus is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction, Cardiotoxicity.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital, Akershus
How many clinical trials has University Hospital, Akershus sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by University Hospital, Akershus, of which 3 are actively recruiting participants. These trials cover conditions including Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Akershus research focus on?
University Hospital, Akershus clinical trials span Breast Cancer, Metastatic Breast Cancer, Cancer Therapy-Related Cardiac Dysfunction, Cardiotoxicity, Heart Failure, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Akershus clinical trial?
To participate in a University Hospital, Akershus trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Akershus trials with current recruitment status updated daily.
Clinical Trials by University Hospital, Akershus
NCT05732051 Phase 2
Recruiting
Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients
Breast Cancer
NCT06721754
Recruiting
Diabetes Related Foot Ulcers With Negative Pressure Wound Therapy
Diabetic Foot Ulcer
NCT04335773
Recruiting
COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology
Pediatric Respiratory Diseases
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology